Use of an oncology sperm bank: a Canadian experience

Authors

  • Amanda Selk Department of Obstetrics and Gynaecology, University of Toronto, Toronto, ON
  • Timea Belej-Rak LifeQuest Centre for Reproductive Medicine, Toronto, ON
  • Heather Shapiro Department of Obstetrics and Gynaecology, University of Toronto and Mount Sinai Hospital, Toronto, ON
  • Ellen Greenblatt Department of Obstetrics and Gynaecology, University of Toronto and Mount Sinai Hospital, Toronto, ON

DOI:

https://doi.org/10.5489/cuaj.1076

Abstract

Background: We performed a retrospective chart review in 2006
to review oncology patients’ use of banked semen samples in
fertility treatments at a tertiary care centre.

Methods: From 2002 to 2005, 367 oncology patients banked
semen. During the same period, 31 patients used banked samples
in 48 treatment cycles. Samples were used for intrauterine insemination
(IUI) in 28 cycles and for in vitro fertilization (IVF) with
or without intracytoplasmic sperm injection (ICSI) in 20 cycles.

Results: Pregnancy rates per cycle were 21% for IUI and 50%
for IVF with or without ICSI. Overall, 16 of the 31 couples achieved
a pregnancy with assisted reproductive technologies (52%).

Conclusion: This data indicates high pregnancy success rates with
the use of banked semen samples from men with cancer.

Contexte : Une revue rétrospective de dossiers a été effectuée afin
d’examiner le recours à des échantillons de sperme provenant
de patients cancéreux pour le traitement de l’infertilité dans un
centre de soins tertiaires.

Méthodes : Entre 2002 et 2005, des échantillons de sperme
provenant d’un total de 367 patients atteints de cancer ont été mis
en banque. Durant la même période, 31 patientes ont utilisé ces
échantillons au cours de 48 cycles de traitement. Les échantillons
ont été utilisés pour insémination intra-utérine (IIU) lors de
28 cycles et pour fertilisation in vitro (FIV) avec ou sans injection
intracytoplasmique de sperme (ICSI) lors de 20 cycles.

Résultats : Le taux de grossesse par cycle était de 21 % avec
l’IIU et de 50 % pour la FIV avec ou sans ICSI. Au total, 16 des
31 patientes sont devenues enceintes (52 %).

Conclusion : Ces données montrent des taux élevés de grossesse
obtenus par l’utilisation d’échantillons de sperme provenant
d’hommes atteints de cancer.

Downloads

Download data is not yet available.

Author Biographies

Amanda Selk, Department of Obstetrics and Gynaecology, University of Toronto, Toronto, ON

Timea Belej-Rak, LifeQuest Centre for Reproductive Medicine, Toronto, ON

Heather Shapiro, Department of Obstetrics and Gynaecology, University of Toronto and Mount Sinai Hospital, Toronto, ON

Ellen Greenblatt, Department of Obstetrics and Gynaecology, University of Toronto and Mount Sinai Hospital, Toronto, ON

Downloads

How to Cite

Selk, A., Belej-Rak, T., Shapiro, H., & Greenblatt, E. (2013). Use of an oncology sperm bank: a Canadian experience. Canadian Urological Association Journal, 3(3), 219–22. https://doi.org/10.5489/cuaj.1076

Issue

Vol. 3 No. 3 (2009): CUAJ June

Section

Original Research

License

You, the Author(s), assign your copyright in and to the Article to the Canadian Urological Association. This means that you may not, without the prior written permission of the CUA:

  • Post the Article on any Web site
  • Translate or authorize a translation of the Article
  • Copy or otherwise reproduce the Article, in any format, beyond what is permitted under Canadian copyright law, or authorize others to do so
  • Copy or otherwise reproduce portions of the Article, including tables and figures, beyond what is permitted under Canadian copyright law, or authorize others to do so.

The CUA encourages use for non-commercial educational purposes and will not unreasonably deny any such permission request.

You retain your moral rights in and to the Article. This means that the CUA may not assert its copyright in such a way that would negatively reflect on your reputation or your right to be associated with the Article.

The CUA also requires you to warrant the following:

  • That you are the Author(s) and sole owner(s), that the Article is original and unpublished and that you have not previously assigned copyright or granted a licence to any other third party;
  • That all individuals who have made a substantive contribution to the article are acknowledged;
  • That the Article does not infringe any proprietary right of any third party and that you have received the permissions necessary to include the work of others in the Article; and
  • That the Article does not libel or violate the privacy rights of any third party.